{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06297200",
            "orgStudyIdInfo": {
                "id": "24-050"
            },
            "organization": {
                "fullName": "Virginia Polytechnic Institute and State University",
                "class": "OTHER"
            },
            "briefTitle": "Low-Intensity Focused Ultrasound and the Complex Patient",
            "officialTitle": "Investigations of Low-Intensity Focused Ultrasound Towards Treatment for the Complex Patient",
            "therapeuticArea": [
                "Mental Health",
                "Other"
            ],
            "study": "low-intensity-focused-ultrasound-and-the-complex-patient"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-19",
            "studyFirstSubmitQcDate": "2024-03-04",
            "studyFirstPostDateStruct": {
                "date": "2024-03-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Wynn Legon",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Virginia Polytechnic Institute and State University"
            },
            "leadSponsor": {
                "name": "Virginia Polytechnic Institute and State University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Salem VA Medical Center",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Washington DC VA Medical Center",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Studying the effects of Low Intensity Focused Ultrasound (LIFU) on measures of pain, craving, and anxiety in a complex patient population."
        },
        "conditionsModule": {
            "conditions": [
                "Opioid Use Disorder",
                "Chronic Pain",
                "Anxiety Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE",
                    "maskingDescription": "Sham trials will be utilized within subject. All subjects will receive sham and ultrasound conditions."
                }
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pain, Craving, and Anxiety measures",
                    "type": "EXPERIMENTAL",
                    "description": "Multi visit - LIFU/Sham. Participants will complete pain, craving, and anxiety measures pre and post intervention.",
                    "interventionNames": [
                        "Device: Low-Intensity Focused Ultrasound",
                        "Device: Low-Intensity Focused Ultrasound - sham"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Low-Intensity Focused Ultrasound",
                    "description": "A noninvasive brain stimulation device using low-intensity focused ultrasound (LIFU) - ultrasound will be used to test whether noninvasive brain stimulation can effect pain, craving, and anxiety.",
                    "armGroupLabels": [
                        "Pain, Craving, and Anxiety measures"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "Low-Intensity Focused Ultrasound - sham",
                    "description": "A sham condition that will mimic the application of LIFU without actually administering any ultrasound to the brain.",
                    "armGroupLabels": [
                        "Pain, Craving, and Anxiety measures"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events via a neurological examination",
                    "description": "Any abnormal finding from the neurological exam will be recorded as an adverse event (AE) and tabulated with the side effects and tolerability data.",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                },
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events via a side effects questionnaire",
                    "description": "Side effects and reported severity will be tabulated and summarized on a 5 point likert scale.",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                },
                {
                    "measure": "Changes in Heart Rate (HR)",
                    "description": "changes in HR compared pre/post LIFU and at follow up",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                },
                {
                    "measure": "Changes in Respiration Rate (RR)",
                    "description": "changes in RR compared pre/post LIFU and at follow up",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                },
                {
                    "measure": "Changes in mood via visual analog mood scale (VAMS) such as the wong-baker face scale.",
                    "description": "changes in mood scale compared pre/post LIFU and at follow up",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                },
                {
                    "measure": "Changes in Blood Pressure (BP)",
                    "description": "changes in BP (systolic and diastolic) compared pre/post LIFU and at follow up",
                    "timeFrame": "Assessed per participant, over the course of participation - an average of 4 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Males and females aged 18-65 years\n2. Current diagnosis of Chronic Back Pain as defined by pain duration of at least three months, with back pain being an ongoing problem for at least half the days of the last six months.\n3. Have evidence of central sensitization (CS) as measured by the Widespread Pain/Symptom Severity Index (WPSSI) with a score of Widespread Pain Index (WPI) \u2265 7 and Symptom Severity (SS) \u2265 5 or WPI = 3-6 and SS \u2265 9.\n4. Meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for current opiate use disorder as diagnosed by the Structured Clinical Interview for DSM-5.\n5. Be in treatment for opioid use disorder (OUD) including buprenorphine or methadone.\n6. Meet the DSM-5 criteria for a current anxiety disorder: generalized anxiety disorder, post-traumatic stress disorder or social anxiety disorder as diagnosed by the Structured Clinical Interview for DSM-5.\n\nExclusion Criteria:\n\n1. Evidence of neuropathic pain\n2. Previous spine surgery\n3. Current substance use disorder other than OUD or tobacco use disorder\n4. Current DSM-5 diagnosis of schizophrenia or schizo-affective disorder\n5. Chronic Pain Conditions other than chronic back pain\n6. Daily opiate use other than buprenorphine/methadone for OUD/pain control\n7. Pregnant or breastfeeding\n8. History of head injury, seizures, neurologic disorders including cerebrovascular disease, stroke, brain surgery, brain tumor, multiple sclerosis, or neurodegenerative diseases\n9. History of metastasizing cancers, inflammatory disorder (rheumatoid arthritis, polymyalgia rheumatica, scleroderma, lupus or polymyositis), unintended weight loss of 20 pounds or more in the last year, or cauda equina syndrome\n10. Ferromagnetic implants or other contraindications for magnetic resonance imaging (MRI)\n11. Evidence of arteriovenous malformation, aneurysm, infarct, meningioma, parenchymal brain tumor or evidence of neurodegenerative processes and/or white matter lesions greater than that expected for age as determined by the study neuroradiologist\n12. Unstable medical conditions such as congestive heart failure, unstable angina, poorly controlled arrhythmia active system infection end stage renal disease",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessica Florig, MPH",
                    "role": "CONTACT",
                    "phone": "540-526-2261",
                    "email": "jnw@vtc.vt.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Fralin Biomedical Research Institute at VTC",
                    "city": "Roanoke",
                    "state": "Virginia",
                    "zip": "24016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Florig, MPH",
                            "role": "CONTACT",
                            "phone": "540-526-2261",
                            "email": "jnw@vtc.vt.edu"
                        },
                        {
                            "name": "Wynn Legon, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.27097,
                        "lon": -79.94143
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000059350",
                    "term": "Chronic Pain"
                },
                {
                    "id": "D000009293",
                    "term": "Opioid-Related Disorders"
                },
                {
                    "id": "D000001008",
                    "term": "Anxiety Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000079524",
                    "term": "Narcotic-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4324",
                    "name": "Anxiety Disorders",
                    "asFound": "Anxiety Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M29442",
                    "name": "Chronic Pain",
                    "asFound": "Chronic Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12244",
                    "name": "Opioid-Related Disorders",
                    "asFound": "Opioid Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M2057",
                    "name": "Narcotic-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}